The Infection Innovation Consortium: iiCON and partners have launched the first human challenge trial for a new vaccine for pneumococcal disease – marking a key milestone in a collaborative global project that is offering new hope in the fight against the disease.

ONE of the region’s most influential property professionals has been appointed to head up the Invest Liverpool City Region (ILCR) Partnership Taskforce.

Running from May 12-23, Innovation Investment Fortnight (IIF) will feature at least 20 events covering topics ranging from the city region’s world-leading life sciences innovation to maritime, space, AI and sports science.

New AI-powered, robotic labs that will accelerate development of new treatments for deadly diseases are to be built in Liverpool after £10m Innovation Zone funding was agreed.

New £10m robotic labs investment for iiCON in plans to ‘supercharge’ Liverpool life sciences.

The Future Innovators Programme encourages young people to learn about the innovation, science and technology career opportunities available in KQ Liverpool, with an aim of creating tangible aspirations.

The Infection Innovation Consortium: iiCON has bolstered its core team, welcoming a cohort of new starters to support operations following strong growth.

Liverpool School of Tropical Medicine and self-funded charitable medical research organisation, LifeArc, are partnering to launch a new Translational Development Fund to help tackle infectious diseases.

iiCON: Infection Innovation Consortium has supported 11 new products to market since launching in September 2020, with a further 16 in the development pipeline.

iiDiagnostics will enable industry engagement and commercial access to the world-leading diagnostics R&D capability and facilities at LSTM.

Plans have been revealed for a new multi-million-pound centre located in Knowledge Quarter Liverpool.

Dr Fiona Marston is to become LSTM’s Entrepreneur in Residence after being awarded a place on the Royal Society’s scheme for 2021.

LSTM has launched a new Transposon Registry, which will serve as a repository of information on all bacterial transposons for the scientific community.

LSTM and the Humanitarian Conflict Response Institute (HCRI) of the University of Manchester have signed a global partnership with a medical charity.